Join
Live feed
·
INSIDERFilingvia Quantisnow
Rigel Pharmaceuticals Inc. logo

Director Frohlich Mark W was granted 5,750 shares, increasing direct ownership by 460% to 7,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RIGL· Rigel Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RIGL (Rigel Pharmaceuticals Inc.) and more on Quantisnow.